Literature DB >> 11856527

Dorsalization of the neural tube by Xenopus tiarin, a novel patterning factor secreted by the flanking nonneural head ectoderm.

Hiroshi Tsuda1, Noriaki Sasai, Mami Matsuo-Takasaki, Makoto Sakuragi, Yoshinobu Murakami, Yoshiki Sasai.   

Abstract

We have isolated a novel secreted dorsalizing factor of the neural tube, Xenopus Tiarin, which belongs to the olfactomedin-related family. Tiarin expression starts at the late gastrula stage in the nonneural ectoderm adjacent to the anterior neural plate. Overexpression of Tiarin in the embryo causes expansion of dorsal neural markers and suppression of ventral markers. In the eye-forming field, Tiarin overexpression induces the retinal markers and represses optic stalk markers. Tiarin directly dorsalizes neural tissues in the absence of mesodermal tissues and antagonizes the ventralizing activity of Sonic hedghog (Shh). Unlike BMP4, another dorsalizing factor, Tiarin does not display antineuralizing activity on the ectoderm or mesoderm-ventralizing activity. These findings show that Tiarin is a novel patterning signal candidate acting in the specification of the dorsal neural tube.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11856527     DOI: 10.1016/s0896-6273(02)00590-1

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  15 in total

Review 1.  Neural plate patterning by secreted signals.

Authors:  Oliver Wessely; E M De Robertis
Journal:  Neuron       Date:  2002-02-14       Impact factor: 17.173

2.  From the black widow spider to human behavior: Latrophilins, a relatively unknown class of G protein-coupled receptors, are implicated in psychiatric disorders.

Authors:  Ariel F Martinez; Maximilian Muenke; Mauricio Arcos-Burgos
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-12       Impact factor: 3.568

3.  Expression, purification, crystallization and preliminary X-ray analysis of the olfactomedin domain from the sea urchin cell-adhesion protein amassin.

Authors:  Brian J Hillier; Vidyasankar Sundaresan; C David Stout; Victor D Vacquier
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-12-16

4.  Significance of G-X-W motif in the myocilin olfactomedin domain.

Authors:  K Rangachari; J Jeyalaxmi; P J Eswari Pandaranayaka; N Prasanthi; P Sundaresan; S R Krishnadas; S Krishnaswamy
Journal:  J Ocul Biol Dis Infor       Date:  2012-06-05

5.  Identification and characterization of photomedins: novel olfactomedin-domain-containing proteins with chondroitin sulphate-E-binding activity.

Authors:  Yutaka Furutani; Ri-ichiroh Manabe; Ko Tsutsui; Tomiko Yamada; Nagisa Sugimoto; Shiro Fukuda; Jun Kawai; Nobuo Sugiura; Koji Kimata; Yoshihide Hayashizaki; Kiyotoshi Sekiguchi
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

6.  Optimedin induces expression of N-cadherin and stimulates aggregation of NGF-stimulated PC12 cells.

Authors:  Hee-Sheung Lee; Stanislav I Tomarev
Journal:  Exp Cell Res       Date:  2006-09-28       Impact factor: 3.905

7.  Zebrafish olfactomedin 1 regulates retinal axon elongation in vivo and is a modulator of Wnt signaling pathway.

Authors:  Naoki Nakaya; Hee-Sheung Lee; Yuichiro Takada; Itai Tzchori; Stanislav I Tomarev
Journal:  J Neurosci       Date:  2008-07-30       Impact factor: 6.167

8.  Myocilin is a modulator of Wnt signaling.

Authors:  Heung-Sun Kwon; Hee-Sheung Lee; Yun Ji; Jeffrey S Rubin; Stanislav I Tomarev
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

9.  Olfactomedin-2 mediates development of the anterior central nervous system and head structures in zebrafish.

Authors:  Ju-Ahng Lee; Robert R H Anholt; Gregory J Cole
Journal:  Mech Dev       Date:  2007-09-29       Impact factor: 1.882

10.  Olfactomedin-like 3 (OLFML3) gene expression in baboon and human ocular tissues: cornea, lens, uvea, and retina.

Authors:  I P Rodríguez-Sánchez; M L Garza-Rodríguez; K Mohamed-Noriega; V S Voruganti; M E Tejero; I Delgado-Enciso; D C Pérez-Ibave; N E Schlabritz-Loutsevitch; J Mohamed-Noriega; M L Martinez-Fierro; D Reséndez-Pérez; S A Cole; H Cavazos-Adame; A G Comuzzie; J Mohamed-Hamsho; H A Barrera-Saldaña
Journal:  J Med Primatol       Date:  2013-02-09       Impact factor: 0.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.